Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Brings world class capabilities and deep expertise in colorectal cancer and other solid tumor indications to advance the clinical development of onvansertib Served as the lead investigator for two ...
Cardiff Oncology appoints Roger Sidhu as CMO; conference call on July 29 to discuss clinical data for onvansertib in mCRC. Cardiff Oncology, Inc. announced the appointment of Roger Sidhu, MD, as its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback